Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions

被引：169

作者：

Michalik, L ^{[1
]}

Wahli, W ^{[1
]}

机构：

[1] Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 1999年 / 10卷 / 06期

关键词：

D O I：

10.1016/S0958-1669(99)00030-0

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The peroxisome proliferator-activated receptors (PPARs) are fatty acid and eicosanoid inducible nuclear receptors, which occur in three different isotypes. Upon activator binding, they modulate the expression of various target genes implicated in several important physiological pathways. During the past few years, the identification of both PPAR ligands, natural and synthetic, and PPAR targets and their associated functions has been one of the most important achievements in the field. It underscores the potential therapeutic application of PPAR-specific compounds on the one side, and the crucial biological roles of endogenous PPAR ligands on the other.

引用

页码：564 / 570

页数：7

共 54 条

[1] Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site [J].

Adams, M ;

Reginato, MJ ;

Shao, DL ;

Lazar, MA ;

Chatterjee, VK .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5128-5132

[2] IDENTIFICATION AND CHARACTERIZATION OF DNA ELEMENTS IMPLICATED IN THE REGULATION OF CYP4A1 TRANSCRIPTION [J].

ALDRIDGE, TC ;

TUGWOOD, JD ;

GREEN, S .

BIOCHEMICAL JOURNAL, 1995, 306 :473-479

[3] Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects [J].

Berger, J ;

Leibowitz, MD ;

Doebber, TW ;

Elbrecht, A ;

Zhang, B ;

Zhou, GC ;

Biswas, C ;

Cullinan, CA ;

Hayes, NS ;

Li, Y ;

Tanen, M ;

Ventre, J ;

Wu, MS ;

Berger, GD ;

Mosley, R ;

Marquis, R ;

Santini, C ;

Sahoo, SP ;

Tolman, RL ;

Smith, RG ;

Moller, DE .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6718-6725

[4] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].

Braissant, O ;

Foufelle, F ;

Scotto, C ;

Dauca, M ;

Wahli, W .

ENDOCRINOLOGY, 1996, 137 (01) :354-366

[5] Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α [J].

Brandt, JM ;

Djouadi, F ;

Kelly, DP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :23786-23792

[6] EFFECTS OF FENOFIBRATE ON ANGIOGRAPHICALLY EXAMINED CORONARY ATHEROSCLEROSIS AND LEFT-VENTRICULAR FUNCTION IN HYPERCHOLESTEROLEMIC PATIENTS [J].

BUNTE, T ;

HAHMANN, HW ;

HELLWIG, N ;

HAU, U ;

BECKER, D ;

DYCKMANS, J ;

KELLER, HE ;

SCHIEFFER, HJ .

ATHEROSCLEROSIS, 1993, 98 (02) :127-138

[7]

Camp HS, 1997, J BIOL CHEM, V272, P10811

[8] Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].

Desvergne, B ;

Wahli, W .

ENDOCRINE REVIEWS, 1999, 20 (05) :649-688

[9] The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].

Devchand, PR ;

Keller, H ;

Peters, JM ;

Vazquez, M ;

Gonzalez, FJ ;

Wahli, W .

NATURE, 1996, 384 (6604) :39-43

[10] Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors [J].

DiRenzo, J ;

Soderstrom, M ;

Kurokawa, R ;

Ogliastro, MH ;

Ricote, M ;

Ingrey, S ;

Horlein, A ;

Rosenfeld, MG ;

Glass, CK .

MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2166-2176

← 1 2 3 4 5 6 →